140 related articles for article (PubMed ID: 30417685)
1. Lung cancer risk stratification using methylation profile in the oral epithelium.
Harada H; Miyamaoto K; Kimura M; Ishigami T; Taniyama K; Okada M
Asian Cardiovasc Thorac Ann; 2019 Feb; 27(2):87-92. PubMed ID: 30417685
[TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation analysis of cancer-related genes in oral epithelial cells of healthy smokers.
De Oliveira SR; Da Silva IC; Mariz BA; Pereira AM; De Oliveira NF
Arch Oral Biol; 2015 Jun; 60(6):825-33. PubMed ID: 25791328
[TBL] [Abstract][Full Text] [Related]
4. Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs.
Bhutani M; Pathak AK; Fan YH; Liu DD; Lee JJ; Tang H; Kurie JM; Morice RC; Kim ES; Hong WK; Mao L
Cancer Prev Res (Phila); 2008 Jun; 1(1):39-44. PubMed ID: 19138934
[TBL] [Abstract][Full Text] [Related]
5. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer.
Harada H; Miyamoto K; Yamashita Y; Taniyama K; Mihara K; Nishimura M; Okada M
Cancer Med; 2015 Oct; 4(10):1536-46. PubMed ID: 26276761
[TBL] [Abstract][Full Text] [Related]
6. Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study.
Powrózek T; Krawczyk P; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Exp Lung Res; 2016 Aug; 42(6):307-13. PubMed ID: 27485611
[TBL] [Abstract][Full Text] [Related]
7. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
8. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer.
Toyooka S; Maruyama R; Toyooka KO; McLerran D; Feng Z; Fukuyama Y; Virmani AK; Zochbauer-Muller S; Tsukuda K; Sugio K; Shimizu N; Shimizu K; Lee H; Chen CY; Fong KM; Gilcrease M; Roth JA; Minna JD; Gazdar AF
Int J Cancer; 2003 Jan; 103(2):153-60. PubMed ID: 12455028
[TBL] [Abstract][Full Text] [Related]
9. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers.
Zöchbauer-Müller S; Lam S; Toyooka S; Virmani AK; Toyooka KO; Seidl S; Minna JD; Gazdar AF
Int J Cancer; 2003 Nov; 107(4):612-6. PubMed ID: 14520700
[TBL] [Abstract][Full Text] [Related]
11. AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality.
Grieshober L; Graw S; Barnett MJ; Thornquist MD; Goodman GE; Chen C; Koestler DC; Marsit CJ; Doherty JA
BMC Cancer; 2020 Sep; 20(1):905. PubMed ID: 32962699
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
13. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer.
Teschendorff AE; Yang Z; Wong A; Pipinikas CP; Jiao Y; Jones A; Anjum S; Hardy R; Salvesen HB; Thirlwell C; Janes SM; Kuh D; Widschwendter M
JAMA Oncol; 2015 Jul; 1(4):476-85. PubMed ID: 26181258
[TBL] [Abstract][Full Text] [Related]
15. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y
PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088
[TBL] [Abstract][Full Text] [Related]
17. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA methylation in lung cancer: biological and clinical implications.
Zöchbauer-Müller S; Minna JD; Gazdar AF
Oncologist; 2002; 7(5):451-7. PubMed ID: 12401908
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
[TBL] [Abstract][Full Text] [Related]
20. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]